Desmoid Clinical Trial
Official title:
The Efficacy and Safety of Anlotinib Combined With Chemotherapy in the Treatment of Unresectable Advanced Desmoid Tumors: a Prospective Single-arm Clinical Study
Thirty patients with desmoid tumors (invasive fibromatosis) will be recruited in the Department of Bone and Soft Tissue, Henan Cancer Hospital. This is a prospective, multicenter, single-arm clinical study to evaluate the efficacy and safety of anlotinib combined with chemotherapy in the treatment of inoperable advanced desmoid tumors.
Thirty patients with desmoid tumor (invasive fibromatosis) will be recruited in the Department of Bone and Soft Tissue, Henan Cancer Hospital. This is a prospective, multicenter, single-arm clinical study to evaluate the efficacy and safety of anlotinib combined with chemotherapy in the treatment of inoperative advanced desmoid tumor. To evaluate the 6-month progression-free survival rate, 12-month progression-free survival rate, progression-free survival (PFS), objective response rate (ORR), disease control rate (DCR) and safety of anlotinib combined with chemotherapy for desmoid tumors. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03966742 -
Doxorubicin Eluting Intra-arterial Embolization for Aggressive Desmoid Fibromatosis
|
Phase 2 | |
| Completed |
NCT03275818 -
Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing Sarcoma
|
Phase 2 | |
| Recruiting |
NCT05091255 -
Cryotherapy in the Treatment of Desmoid Tumors
|
N/A | |
| Active, not recruiting |
NCT04871282 -
A Study of AL102 in Patients With Progressing Desmoid Tumors
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05284305 -
Desmoid Tumor and Pregnancy: Effect of Pregnancy on Disease Control and Effect of Diagnosis on Pregnancy History.
|
||
| Active, not recruiting |
NCT01273168 -
Endoxifen in Adults With Hormone Receptor Positive Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT06224283 -
Radiomics Compared With Conventional Response Criteria for Predicting Progression of Desmoid Tumor After Cryoablation
|
||
| Recruiting |
NCT06268457 -
Arterial Chemoembolization for the Treatment of Desmoid Fibromatosis
|
||
| Withdrawn |
NCT02557854 -
HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors
|
Phase 1 | |
| Not yet recruiting |
NCT06355921 -
A Prospective Clinical Study on the Safety and Efficacy of Radiofrequency Ablation for the Treatment of Patients With Desmoid Tumors
|
N/A |